About: Pharmaceuticals policy

Property	Value
dbo:wikiPageID	4216042 (xsd:integer)
dbo:wikiPageRevisionID	975677382 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Commons_category dbt:CatAutoTOC dbt:Cat_main
rdf:type	skos:Concept
rdfs:label	Pharmaceuticals policy (en)
skos:broader	dbc:Drug_policy dbc:Health_care_industry dbc:Pharmacy dbc:Health_policy
skos:prefLabel	Pharmaceuticals policy (en)
prov:wasDerivedFrom	wikipedia-en:Category:Pharmaceuticals_policy?oldid=975677382&ns=14
owl:sameAs	dbc:Pharmaceuticals_policy
is dbo:wikiPageWikiLink of	dbr:American_Society_of_Pharmacognosy dbr:Prescription_Drug_Marketing_Act dbr:Prescription_Drug_User_Fee_Act dbr:Prescription_monitoring_program dbr:List_of_antibiotic-resistant_bacteria dbr:MIMS_Ireland dbr:Regulation_of_therapeutic_goods dbr:Antibiotic_misuse dbr:Antibiotic_use_in_livestock dbr:Antimicrobial_resistance dbr:Antimicrobial_resistance_in_Australia dbr:Pharmaceutical_Inspection_Convention_a...utical_Inspection_Co-operation_Scheme dbr:Pharmacovigilance dbr:Pharmacovigilance_Programme_of_India dbr:Vaccination_policy dbr:Vaccination_policy_of_the_United_States dbr:Deprescribing dbr:Deutscher_Apothekerverband_v_0800_DocMorris_NV dbr:EUDRANET dbr:Initiative_for_Medicines,_Access,_and_Knowledge dbr:International_Council_for_Harmonisatio...nts_for_Pharmaceuticals_for_Human_Use dbr:International_Society_for_Pharmacoepidemiology dbr:International_Society_of_Pharmacovigilance dbr:Joel_Lexchin dbr:KwikMed dbr:Postmarketing_surveillance dbr:Prescription_drug_prices_in_the_United_States dbr:Prescription_drug_purchasing_pool dbr:Verified-Accredited_Wholesale_Distributors dbr:Medical_cannabis dbr:Medicare_Prescription_Drug,_Improvement,_and_Modernization_Act dbr:Chilean_pharmaceutical_policy dbr:Elixir_sulfanilamide dbr:Essential_medicines_policies dbr:Generic_drug dbr:Orphan_drug dbr:Over-the-counter_drug dbr:Swissmedic dbr:Multidrug-resistant_tuberculosis dbr:NPS_MedicineWise dbr:Consumer_health_laws dbr:Contract_research_organization dbr:2012_Pakistan_fake_medicine_crisis dbr:Side_Effects_(2005_film) dbr:Clinical_Trials_Directive dbr:Common_Technical_Document dbr:Patient_group_directions dbr:Pharmaceutical_Benefits_Scheme dbr:Medicare_Part_D dbr:Medicare_Part_D_coverage_gap dbr:Medication_discontinuation dbr:Medicines_Act_1968 dbr:Medicines_reconciliation dbr:Drug_Efficacy_Study_Implementation dbr:Drug_labelling dbr:Drug_nomenclature dbr:Drugs_controlled_by_the_German_Betäubungsmittelgesetz dbr:Health_Impact_Fund dbr:Health_Products_and_Food_Branch dbr:Irwin_screen dbr:Qualified_person_(European_Union) dbr:No_Free_Lunch_(organization) dbr:Qualified_Person_Responsible_For_Pharmacovigilance dbr:2006_Oregon_Ballot_Measure_44 dbr:Drug_Quality_and_Security_Act dbr:Drug_utilization_review dbr:Durham–Humphrey_Amendment dbr:EuroPharm_Forum dbr:Federal_Food,_Drug,_and_Cosmetic_Act dbr:First_Databank dbr:Formulary_(pharmacy) dbr:British_National_Formulary_for_Children dbr:Directive_2001/83/EC dbr:Directive_65/65/EEC dbr:Directive_75/318/EEC dbr:Directive_75/319/EEC dbr:Directive_93/41/EEC dbr:Falsified_Medicines_Directive dbr:Food_and_Drug_Administration_Modernization_Act_of_1997 dbr:Good_Clinical_Practice_Directive dbr:Good_manufacturing_practice dbr:LegitScript dbr:List_of_medicine_contamination_incidents dbr:Test_data_exclusivity dbr:Prescription_drug dbr:International_Union_of_Basic_and_Clinical_Pharmacology dbr:Council_for_International_Organizations_of_Medical_Sciences dbr:Counterfeit_medications dbr:Access_to_Cannabis_for_Medical_Purposes_Regulations dbr:Advocates_for_Opioid_Recovery dbr:Kefauver–Harris_Amendment dbr:Biotechnology_industry_in_China dbr:Traceability dbr:Yellow_Card_Scheme dbr:Regenerative_Medicine_Advanced_Therapy dbr:Sakigake_(drug_designation) dbr:Authorized_generics dbr:IPLEDGE_program dbr:Orphan_Drug_Act_of_1983 dbr:Campaign_for_Access_to_Essential_Medicines dbr:Canada's_Access_to_Medicines_Regime dbr:Canadian_Agency_for_Drugs_and_Technologies_in_Health dbr:Certificate_of_pharmaceutical_product dbr:Seneka_Bibile dbr:NHS_treatments_blacklist dbr:Marketing_authorisation dbr:Uppsala_Monitoring_Centre dbr:Wootton_Report dbr:Unused_drug dbr:Vaccine_resistance dbr:EudraGMP dbr:EudraLex dbr:EudraPharm dbr:EudraVigilance dbr:FDA_Food_Safety_Modernization_Act dbr:Ohio_Automated_Rx_Reporting_System dbr:Pharmaceutical_fraud dbr:Pharmaceutical_Press dbr:Pledge_to_Africa_Act dbr:First-in-class_medication dbr:Society_of_Pharmacovigilance,_India dbr:National_Medicinal_Drugs_Policy dbr:Title_21_CFR_Part_11 dbr:VigiBase dbr:T1International dbr:Online_pharmacy dbr:The_Constant_Gardener dbr:The_Rhetoric_of_Drugs dbr:Pharmac dbr:Pharmaceutical_Price_Regulation_Scheme dbr:Pharmaceutical_distribution dbr:Pharmaceutical_industry_in_China dbr:Pharmaceutical_marketing dbr:Pharmaceutical_policy dbr:Therapeutic_Goods_Act_1989 dbr:Special_prescription_form dbr:Sri_Lanka_National_Pharmaceuticals_Policy
is dcterms:subject of	dbr:American_Society_of_Pharmacognosy dbr:Prescription_Drug_Marketing_Act dbr:Prescription_Drug_User_Fee_Act dbr:Prescription_monitoring_program dbr:List_of_antibiotic-resistant_bacteria dbr:MIMS_Ireland dbr:Regulation_of_therapeutic_goods dbr:Antibiotic_misuse dbr:Antibiotic_use_in_livestock dbr:Antimicrobial_resistance dbr:Antimicrobial_resistance_in_Australia dbr:Pharmaceutical_Inspection_Convention_a...utical_Inspection_Co-operation_Scheme dbr:Pharmacovigilance dbr:Pharmacovigilance_Programme_of_India dbr:Vaccination_policy dbr:Vaccination_policy_of_the_United_States dbr:Deprescribing dbr:Deutscher_Apothekerverband_v_0800_DocMorris_NV dbr:EUDRANET dbr:Initiative_for_Medicines,_Access,_and_Knowledge dbr:International_Council_for_Harmonisatio...nts_for_Pharmaceuticals_for_Human_Use dbr:International_Society_for_Pharmacoepidemiology dbr:International_Society_of_Pharmacovigilance dbr:Joel_Lexchin dbr:KwikMed dbr:Postmarketing_surveillance dbr:Prescription_drug_prices_in_the_United_States dbr:Prescription_drug_purchasing_pool dbr:Verified-Accredited_Wholesale_Distributors dbr:Medical_cannabis dbr:Medicare_Prescription_Drug,_Improvement,_and_Modernization_Act dbr:Chilean_pharmaceutical_policy dbr:Elixir_sulfanilamide dbr:Essential_medicines_policies dbr:Generic_drug dbr:Orphan_drug dbr:Over-the-counter_drug dbr:Swissmedic dbr:Multidrug-resistant_tuberculosis dbr:NPS_MedicineWise dbr:Consumer_health_laws dbr:Contract_research_organization dbr:2012_Pakistan_fake_medicine_crisis dbr:Side_Effects_(2005_film) dbr:Clinical_Trials_Directive dbr:Common_Technical_Document dbr:Patient_group_directions dbr:Pharmaceutical_Benefits_Scheme dbr:Medicare_Part_D dbr:Medicare_Part_D_coverage_gap dbr:Medication_discontinuation dbr:Medicines_Act_1968 dbr:Medicines_reconciliation dbr:Drug_Efficacy_Study_Implementation dbr:Drug_labelling dbr:Drug_nomenclature dbr:Drugs_controlled_by_the_German_Betäubungsmittelgesetz dbr:Health_Impact_Fund dbr:Health_Products_and_Food_Branch dbr:Irwin_screen dbr:Qualified_person_(European_Union) dbr:No_Free_Lunch_(organization) dbr:Qualified_Person_Responsible_For_Pharmacovigilance dbr:2006_Oregon_Ballot_Measure_44 dbr:Drug_Quality_and_Security_Act dbr:Drug_utilization_review dbr:Durham–Humphrey_Amendment dbr:EuroPharm_Forum dbr:Federal_Food,_Drug,_and_Cosmetic_Act dbr:First_Databank dbr:Formulary_(pharmacy) dbr:British_National_Formulary_for_Children dbr:Directive_2001/83/EC dbr:Directive_65/65/EEC dbr:Directive_75/318/EEC dbr:Directive_75/319/EEC dbr:Directive_93/41/EEC dbr:Falsified_Medicines_Directive dbr:Food_and_Drug_Administration_Modernization_Act_of_1997 dbr:Good_Clinical_Practice_Directive dbr:Good_manufacturing_practice dbr:LegitScript dbr:List_of_medicine_contamination_incidents dbr:Test_data_exclusivity dbr:Prescription_drug dbr:International_Union_of_Basic_and_Clinical_Pharmacology dbr:Council_for_International_Organizations_of_Medical_Sciences dbr:Counterfeit_medications dbr:Access_to_Cannabis_for_Medical_Purposes_Regulations dbr:Advocates_for_Opioid_Recovery dbr:Kefauver–Harris_Amendment dbr:Biotechnology_industry_in_China dbr:Traceability dbr:Yellow_Card_Scheme dbr:Regenerative_Medicine_Advanced_Therapy dbr:Sakigake_(drug_designation) dbr:Authorized_generics dbr:IPLEDGE_program dbr:Orphan_Drug_Act_of_1983 dbr:Campaign_for_Access_to_Essential_Medicines dbr:Canada's_Access_to_Medicines_Regime dbr:Canadian_Agency_for_Drugs_and_Technologies_in_Health dbr:Certificate_of_pharmaceutical_product dbr:Seneka_Bibile dbr:NHS_treatments_blacklist dbr:Marketing_authorisation dbr:Uppsala_Monitoring_Centre dbr:Wootton_Report dbr:Unused_drug dbr:Vaccine_resistance dbr:EudraGMP dbr:EudraLex dbr:EudraPharm dbr:EudraVigilance dbr:FDA_Food_Safety_Modernization_Act dbr:Ohio_Automated_Rx_Reporting_System dbr:Pharmaceutical_fraud dbr:Pharmaceutical_Press dbr:Pledge_to_Africa_Act dbr:First-in-class_medication dbr:Society_of_Pharmacovigilance,_India dbr:National_Medicinal_Drugs_Policy dbr:Title_21_CFR_Part_11 dbr:VigiBase dbr:T1International dbr:Online_pharmacy dbr:The_Constant_Gardener dbr:The_Rhetoric_of_Drugs dbr:Pharmac dbr:Pharmaceutical_Price_Regulation_Scheme dbr:Pharmaceutical_distribution dbr:Pharmaceutical_industry_in_China dbr:Pharmaceutical_marketing dbr:Pharmaceutical_policy dbr:Therapeutic_Goods_Act_1989 dbr:Special_prescription_form dbr:Sri_Lanka_National_Pharmaceuticals_Policy
is skos:broader of	dbc:Orphan_drugs dbc:Breakthrough_therapy dbc:Orphan_drug_companies dbc:Pharmaceutical_regulation_in_the_United_States dbc:Antimicrobial_resistance